Ativo Capital Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Ativo Capital Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-130,642	Closed	-$1.14M	–	238
2018 Q2	$1.14M	Buy	130,642 +6,007	+5%	+$54K	0.32%	125
2018 Q1	$1.26M	Buy	+124,635	New	+$1.05M	0.36%	112

Ativo Capital Management's JNP Position: Q3 2018 in Review

Ativo Capital Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 130,642 shares — an estimated $1.14M sold.

Ativo Capital Management first reported a position in JNP in Q1 2018 and held it in 2 quarters. The position peaked at $1.26M in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Ativo Capital Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Ativo Capital Management sold 130,642 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $1.14M.
Ativo Capital Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 2 quarters.
Ativo Capital Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1.26M in Q1 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Ativo Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.